Nedosiran sodium
Nedosiran sodium is a GalNAc-conjugated double-stranded RNA therapeutic designed to inhibit hepatic lactate dehydrogenase (LDH) production. It is a research tool for studying LDH's role in primary hyperoxaluria and metabolic disorders, with applications in both in vitro and in vivo experimental models.
Product Specifications
CAS Number
2247026-22-6
Field of Research
Metabolism Research
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog